Compare Cadila Healthcare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs J.B.CHEMICALS - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE J.B.CHEMICALS CADILA HEALTHCARE/
J.B.CHEMICALS
 
P/E (TTM) x 14.5 16.8 86.4% View Chart
P/BV x 2.8 2.3 122.1% View Chart
Dividend Yield % 1.4 0.5 285.4%  

Financials

 CADILA HEALTHCARE   J.B.CHEMICALS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
J.B.CHEMICALS
Mar-18
CADILA HEALTHCARE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs558363 153.7%   
Low Rs362255 141.8%   
Sales per share (Unadj.) Rs116.3169.1 68.8%  
Earnings per share (Unadj.) Rs17.916.6 107.6%  
Cash flow per share (Unadj.) Rs23.123.4 98.8%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.80.6 117.6%  
Book value per share (Unadj.) Rs85.4172.5 49.5%  
Shares outstanding (eoy) m1,023.7483.57 1,225.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.01.8 216.4%   
Avg P/E ratio x25.718.6 138.2%  
P/CF ratio (eoy) x19.913.2 150.6%  
Price / Book Value ratio x5.41.8 300.4%  
Dividend payout %19.612.0 162.6%   
Avg Mkt Cap Rs m470,66425,827 1,822.4%   
No. of employees `00011.83.8 313.3%   
Total wages/salary Rs m18,5452,511 738.6%   
Avg. sales/employee Rs Th10,072.73,747.4 268.8%   
Avg. wages/employee Rs Th1,569.1665.7 235.7%   
Avg. net profit/employee Rs Th1,547.7367.8 420.8%   
INCOME DATA
Net Sales Rs m119,04914,135 842.2%  
Other income Rs m1,132366 309.5%   
Total revenues Rs m120,18114,501 828.8%   
Gross profit Rs m28,4752,178 1,307.2%  
Depreciation Rs m5,388570 945.8%   
Interest Rs m91135 2,610.3%   
Profit before tax Rs m23,3081,940 1,201.8%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644552 1,021.9%   
Profit after tax Rs m18,2921,387 1,318.6%  
Gross profit margin %23.915.4 155.2%  
Effective tax rate %24.228.5 85.0%   
Net profit margin %15.49.8 156.6%  
BALANCE SHEET DATA
Current assets Rs m82,00510,470 783.2%   
Current liabilities Rs m60,7202,749 2,208.8%   
Net working cap to sales %17.954.6 32.7%  
Current ratio x1.43.8 35.5%  
Inventory Days Days7355 132.5%  
Debtors Days Days9878 126.6%  
Net fixed assets Rs m83,7035,811 1,440.4%   
Share capital Rs m1,024167 612.8%   
"Free" reserves Rs m86,42114,248 606.5%   
Net worth Rs m87,44514,416 606.6%   
Long term debt Rs m25,5510-   
Total assets Rs m180,65317,649 1,023.6%  
Interest coverage x26.656.6 47.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.8 82.3%   
Return on assets %10.68.1 131.9%  
Return on equity %20.99.6 217.4%  
Return on capital %22.013.7 160.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,6836,164 692.5%   
Fx outflow Rs m11,2421,334 842.5%   
Net fx Rs m31,4414,829 651.0%   
CASH FLOW
From Operations Rs m9,1931,231 747.1%  
From Investments Rs m-9,737-208 4,679.0%  
From Financial Activity Rs m515-595 -86.5%  
Net Cashflow Rs m-29427 -6.8%  

Share Holding

Indian Promoters % 74.8 55.4 135.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.3 3.4 244.8%  
FIIs % 5.9 3.9 151.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 37.0 29.7%  
Shareholders   44,069 30,437 144.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   AUROBINDO PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

WPI Inflation Data, Global Stock Market Drivers, and Top Cues in Focus Today(Pre-Open)

On Monday, Indian share markets witnessed negative trading activity throughout the day and ended lower.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 16, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS